UPDATE 1-Valeant Q2 tops Street, ups FY10 earnings view
Aug 2 (Reuters) - Valeant Pharmaceuticals International posted quarterly results that beat market estimates driven by strong product sales, and raised its full year 2010 profit view.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here